179 related articles for article (PubMed ID: 15309343)
21. Gliadin-specific T cell responses in peripheral blood of healthy individuals involve T cells restricted by the coeliac disease associated DQ2 heterodimer.
Jensen K; Sollid LM; Scott H; Paulsen G; Kett K; Thorsby E; Lundin KE
Scand J Immunol; 1995 Jul; 42(1):166-70. PubMed ID: 7543212
[TBL] [Abstract][Full Text] [Related]
22. Gliadin-reactive T cells in Italian children from preventCD cohort at high risk of celiac disease.
Camarca A; Auricchio R; Picascia S; Fierro O; Maglio M; Miele E; Malamisura B; Greco L; Troncone R; Gianfrani C
Pediatr Allergy Immunol; 2017 Jun; 28(4):362-369. PubMed ID: 28339124
[TBL] [Abstract][Full Text] [Related]
23. Modelling of HLA-DQ2 and its interaction with gluten peptides to explain molecular recognition in celiac disease.
Costantini S; Rossi M; Colonna G; Facchiano AM
J Mol Graph Model; 2005 Apr; 23(5):419-31. PubMed ID: 15781184
[TBL] [Abstract][Full Text] [Related]
24. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma.
Al-Toma A; Goerres MS; Meijer JW; Peña AS; Crusius JB; Mulder CJ
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):315-9. PubMed ID: 16527694
[TBL] [Abstract][Full Text] [Related]
25. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease.
Molberg O; Mcadam SN; Körner R; Quarsten H; Kristiansen C; Madsen L; Fugger L; Scott H; Norén O; Roepstorff P; Lundin KE; Sjöström H; Sollid LM
Nat Med; 1998 Jun; 4(6):713-7. PubMed ID: 9623982
[TBL] [Abstract][Full Text] [Related]
26. HLA-DR53 molecules are associated with susceptibility to celiac disease and selectively bind gliadin-derived peptides.
Clot F; Gianfrani C; Babron MC; Bouguerra F; Southwood S; Kagnoff MF; Troncone R; Percopo S; Eliaou JF; Clerget-Darpoux F; Sette A; Greco L
Immunogenetics; 1999 Aug; 49(9):800-7. PubMed ID: 10398807
[TBL] [Abstract][Full Text] [Related]
27. Design of gliadin peptide analogues with low affinity for the celiac disease associated HLA-DQ2 protein.
Fraccalvieri D; Motta S; Galliani G; Cavaletti L; Bonati L
Mol Biosyst; 2014 Aug; 10(8):2064-73. PubMed ID: 24841193
[TBL] [Abstract][Full Text] [Related]
28. Development of gliadin-specific immune responses in children with HLA-associated genetic risk for celiac disease.
Lammi A; Arikoski P; Hakulinen A; Schwab U; Uusitupa M; Heinonen S; Savilahti E; Kinnunen T; Ilonen J
Scand J Gastroenterol; 2016; 51(2):168-77. PubMed ID: 26161465
[TBL] [Abstract][Full Text] [Related]
29. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
Dørum S; Qiao SW; Sollid LM; Fleckenstein B
J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
[TBL] [Abstract][Full Text] [Related]
30. An influence of HLA-A, B, DR, DQ, and MICA on the occurrence of Celiac disease in patients with type 1 diabetes.
Bratanic N; Smigoc Schweiger D; Mendez A; Bratina N; Battelino T; Vidan-Jeras B
Tissue Antigens; 2010 Sep; 76(3):208-15. PubMed ID: 20492597
[TBL] [Abstract][Full Text] [Related]
31. On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes.
Busch R; De Riva A; Hadjinicolaou AV; Jiang W; Hou T; Mellins ED
Expert Rev Mol Med; 2012 Jul; 14():e15. PubMed ID: 22805744
[TBL] [Abstract][Full Text] [Related]
32. Celiac Immunogenic Potential of α-Gliadin Epitope Variants from
Ruiz-Carnicer Á; Comino I; Segura V; Ozuna CV; Moreno ML; López-Casado MÁ; Torres MI; Barro F; Sousa C
Nutrients; 2019 Jan; 11(2):. PubMed ID: 30678169
[TBL] [Abstract][Full Text] [Related]
33. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.
Molberg O; McAdam S; Lundin KE; Kristiansen C; Arentz-Hansen H; Kett K; Sollid LM
Eur J Immunol; 2001 May; 31(5):1317-23. PubMed ID: 11465088
[TBL] [Abstract][Full Text] [Related]
34. Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition.
Sjöström H; Lundin KE; Molberg O; Körner R; McAdam SN; Anthonsen D; Quarsten H; Norén O; Roepstorff P; Thorsby E; Sollid LM
Scand J Immunol; 1998 Aug; 48(2):111-5. PubMed ID: 9716100
[TBL] [Abstract][Full Text] [Related]
35. Evidence that HLA-DQ9 confers risk to celiac disease by presence of DQ9-restricted gluten-specific T cells.
Bodd M; Tollefsen S; Bergseng E; Lundin KE; Sollid LM
Hum Immunol; 2012 Apr; 73(4):376-81. PubMed ID: 22342873
[TBL] [Abstract][Full Text] [Related]
36. [Molecular mechanisms behind the immunological reaction against gluten in patients with celiac disease].
Nielsen C; Husby S; Lillevang ST
Ugeskr Laeger; 2003 Feb; 165(9):917-20. PubMed ID: 12661516
[TBL] [Abstract][Full Text] [Related]
37. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies.
Bao F; Yu L; Babu S; Wang T; Hoffenberg EJ; Rewers M; Eisenbarth GS
J Autoimmun; 1999 Aug; 13(1):143-8. PubMed ID: 10441179
[TBL] [Abstract][Full Text] [Related]
38. Overview of biomarkers for diagnosis and monitoring of celiac disease.
Brusca I
Adv Clin Chem; 2015; 68():1-55. PubMed ID: 25858867
[TBL] [Abstract][Full Text] [Related]
39. Effect of HLA DQ2, dietary exposure and coeliac disease on the development of antibody response to gliadin in children.
Ludvigsson JF; Eylert M; Ilonen J; Ludvigson J; Vaarala O
Scand J Gastroenterol; 2006 Aug; 41(8):919-28. PubMed ID: 16803690
[TBL] [Abstract][Full Text] [Related]
40. Molecular basis of celiac disease.
Sollid LM
Annu Rev Immunol; 2000; 18():53-81. PubMed ID: 10837052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
